Form D · Biotechnology
Rainier Therapeutics, Inc.
San Leandro, CA · CIK 0001605096
Offering snapshot reported Jul 26, 2019 · SEC filing
- Reported sold
- $10M Offering amount: $19.2M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 26, 2019 | Initial | $10,000,000 | No comparison | 10 | SEC filing |
| Feb 12, 2019 | Initial | $9,999,996 | No comparison | 10 | SEC filing |
| May 14, 2018 | Amendment | $50,003,996 | $30,003,996vs Mar 21, 2017 | 9 | SEC filing |
| Mar 21, 2017 | Initial | $20,000,000 | No comparison | 8 | SEC filing |
| Jun 4, 2014 | Initial | $9,982,500 | No comparison | 1 | SEC filing |
| Apr 17, 2014 | Initial | $6,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-345146
Offer and Sale of Convertible Promissory Notes and the shares issuable thereunder
Source: Form D, filed Jul 26, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Abella | Executive |
| Fouad Azzam | Director |
| Thomas Boone | Director |
| Graeme Currie | Executive |
| Julie M. Eastland | Executive |
| Eric Emery | Executive |
| Brent D. Fassett | Executive |
| Cory Freedland | Director |
| Jocelyn Holash | Executive |
| Joel Jean Mairet | Director |
| David Kabakoff | Director |
| Stephen W. Lau | Director, Executive |
| Peter Moldt | Director |
| Scott D. Myers | Director, Executive |
| Jack Nielsen | Director |
| Christian Richard | Director |
| Kenneth Schwartz | Executive |
| Martin Steen | Director |
| Marten Steen | Director |
| Joseph L. Turner | Director |
| Eric Yuen | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1040 Davis Street, Suite 202
San Leandro, CA, 94577
San Leandro, CA, 94577